Benjamin Boyerinas
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 5
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Marcus E. Peter (4 shared papers)Andrea E. Murmann (3 shared papers)Sun-Mi Park (2 shared papers)Annika Hau (1 shared paper)Jeffrey Schlom (7 shared papers)Caroline Jochéms (6 shared papers)James L. Gulley (5 shared papers)Christopher R. Heery (3 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (3 papers)Cancer Research (3 papers)Blood (2 papers)Cancer Immunology Immunotherapy (2 papers)Molecular Cell (1 paper)
- Partner nations
- United StatesDenmarkMalaysia
In The Last Decade
Benjamin Boyerinas
16 papers receiving 1.7k citations
Benjamin Boyerinas's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 643
- Oncology 564
- Immunology 334
- Molecular Biology 903
- Aging 13
Countries citing papers authored by Benjamin Boyerinas
This map shows the geographic impact of Benjamin Boyerinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Boyerinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Boyerinas more than expected).
Fields of papers citing papers by Benjamin Boyerinas
This network shows the impact of papers produced by Benjamin Boyerinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Boyerinas. The network helps show where Benjamin Boyerinas may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Boyerinas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The role of let-7 in cell differentiation and cancer Hit paper breakdown → | 2009 | 539 |
| 2 | 2015 | 370 | |
| 3 | 2008 | 188 | |
| 4 | 2013 | 184 | |
| 5 | 2011 | 138 | |
| 6 | 2005 | 123 | |
| 7 | 2023 | 67 | |
| 8 | 2016 | 38 | |
| 9 | 2013 | 20 | |
| 10 | 2014 | 19 | |
| 11 | 2015 | 5 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 4 | |
| 14 | 2014 | 3 | |
| 15 | 2015 | 2 | |
| 16 | 2013 | 2 |
About Benjamin Boyerinas
Benjamin Boyerinas is a scholar working on Oncology, Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 16 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers), MicroRNA in disease regulation (3 papers), Carbohydrate Chemistry and Synthesis (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (643 citations), Oncology (564 citations), Immunology (334 citations), Molecular Biology (903 citations) and Aging (13 citations). Benjamin Boyerinas has collaborated with scholars based in United States, Denmark and Malaysia. Frequent co-authors include Marcus E. Peter, Andrea E. Murmann, Sun-Mi Park, Annika Hau, Jeffrey Schlom, Caroline Jochéms, James L. Gulley, Christopher R. Heery, Massimo Fantini and Kwong Y. Tsang. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cancer Research, Blood, Cancer Immunology Immunotherapy and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.